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ABSTRACT 
Introduction: The Physiological Profile Assessment (PPA) is used in research and clinical 
practice for assessing fall risk. We compared PPA test performance between people with 
Multiple Sclerosis (MS) and healthy controls, determined the fall-risk profile for people with 
MS and developed a reference database for people with MS. 
Methods: 416 ambulant people with MS (51.5±12.0 years) and 352 controls (52.8±12.2 
years) underwent the PPA (tests of contrast sensitivity, proprioception, quadriceps strength, 
reaction time and sway) with composite fall risk scores computed from these measures. MS 
participants were followed prospectively for falls for three months. 
Results: The MS participants performed significantly worse than controls in each PPA test. 
The average composite fall-risk score was also significantly elevated indicating a “marked” 
fall-risk when compared to controls. 155 MS participants (37.3%) reported 2+ falls in the 
follow-up period. Frequent fallers performed significantly worse than non-frequent fallers in 
the contrast sensitivity, reaction time and sway tests and had higher PPA composite scores. 
Conclusions: In line with poor PPA test performances, falls incidence in people with MS 
was high. This study provides comprehensive reference data for the PPA measures for people 
with MS that could be used to inform future research and clinical practice. 
Word count = 199 
INTRODUCTION 
Falls are common among people with multiple sclerosis (MS) and knowledge about fall risk 
factors in MS has increased significantly in the last decade. About 60% of people with MS 
will fall at least once and more than 30% will fall three or more times across a three to twelve 
month period1-3. Identified risk factors associated with falls include advanced disease status1, 
3, 4, balance impairments2, 5, 6, slow choice stepping reaction time, reduced walking speed, 
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reduced executive functioning2, weakness in the lower limbs6, use of walking aids6-8, fear of 
falling9, 10, forgetfulness9, bladder incontinence9 and fatigue11. 
A number of tests have been used to estimate fall risk in this group. These have included 
clinical assessments such as the Berg Balance Scale (BBS) and the Timed Up and Go (TUG) 
Test 12 and laboratory-based tests such as posturography involving moving force-plates and 
visual surrounds13. There is some evidence that the clinical assessments can discriminate 
between people with MS who do and do not fall14, 15 but these tests have limitations in that 
they are restricted to measures of functional balance, and not broad ranging physiological 
impairments. It has been shown the BBS has a ceiling effect in higher functioning adults16 
and the predictive capacity of the TUG test is at best moderate in community ambulant older 
people17. Other simple tools, such as the Physiological Profile Assessment (PPA)18 may 
complement functional balance tests and have value in evaluating fall risk in people with 
MS2, 3. 
The PPA provides quantitative measures of key physiological risk factors for falls, including 
lower limb strength, sensation, balance during quiet standing, vision and hand reaction time. 
The PPA was designed to be low-tech, portable, simple and quick to administer and able to 
produce valid and reliable quantitative measures16. The PPA generates quantitative scores for 
each test domain as well as a summed, weighted total risk score. PPA component and fall risk 
scores have been shown to have good predictive ability of falls in community-dwelling older 
people and clinical groups including people with MS2, 3.  
The aims of this study were to a) examine whether PPA component and composite test 
performance scores discriminate between frequent and non-frequent fallers in people with 
MS, b) compare these scores of people with MS with data from age-matched healthy controls 
and c) develop a reference database of PPA fall risk scores for people with MS. These 
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findings could help identify people with MS at increased risk of falling and be used to 
evaluate the effectiveness of fall prevention programs aimed at improving physical 
performance outcomes. 
  METHODS 
Protocol Approvals and Participant Consent 
The data used in the current analysis were obtained from prospective cohort studies of fall 
risk in people with MS carried out in Australia (AUS), United Kingdom (UK) and the United 
States (US). These studies were approved by local ethics committees and written informed 
consent was obtained from all participants.  
MS Participants 
Data from 416 people with MS were included in this analysis: 210 participants from AUS, 
148 from the UK and 58 from the US. Common inclusion criteria for all samples were: a) 
participants were diagnosed with MS using standardized criteria for MS diagnosis19, 20 and b) 
participants were aged 18 years and older without restriction of any MS subtypes. Common 
exclusion criteria were inability to understand and sign an informed consent or being unable 
to follow test instructions. 
Additional inclusion criteria for the Australian sample were ability to stand unsupported for 
30 seconds and ability to walk 10 meters with or without a mobility aid (i.e. Disease Steps 0-
519, Appendix 1). The UK participants were restricted to an EDSS score between 3.5 and 6.5, 
and full recovery from any recent relapse was required for inclusion. The US sample included 
participants with an EDSS score of 6.0 or less, an upper age limit of 50 years, being relapse 
free for 30 days prior to baseline examination, and ability to walk at least 100 meters. EDSS 
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was assessed either face-to-face by a trained clinician or by self-report using a telephone 
interview20. Disease severity was measured by the EDSS21 in the samples from the UK and 
the US. In Australia the Disease Steps scale19 was used and converted to EDSS by mobility 
criteria. 
The Australian sample was recruited from an outpatient MS physiotherapy clinic in Sydney. 
Participants in the UK sample were recruited via invitation letters from their local neurologist 
and an advertisement in the newsletter of the South West Impact of MS (SWIMS) project, 
which is accessed by over 1500 people with MS living in the South West of England22. The 
US sample was recruited from patients receiving medical care at specialty MS center 
outpatient clinics at a Department of Veterans Affairs medical center and a university 
medical center, and from the surrounding area, in the Northwest of the United States. 
Demographic information including age, gender, number of years diagnosed with MS and 
type of MS was collected using a structured questionnaire. Trained therapists also assessed 
participants’ level of disability (EDSS scores21 or Disease Steps19). 
Control participants without MS 
Data for 352 age-matched healthy participants were randomly selected from the databases of 
research studies conducted at Neuroscience Research Australia23, 24  and the University of 
Queensland25-28. Participants for these studies were generally representative of the general 
population and were recruited via the electoral roll, health insurance databases and 
convenience sampling. Exclusion criteria were: having a neurological condition such as MS, 
Parkinson’s disease or stroke, an MMSE score < 24 (indicating probable dementia)29 and 
speaking no or very little English. 
Physiological Profile Assessment (PPA) 
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The Physiological Profile Assessment (PPA) comprises five sensorimotor and balance 
measures: visual contrast sensitivity, proprioception, quadriceps muscle strength, hand 
reaction time, and postural sway.  
Visual contrast sensitivity was assessed using the Melbourne Edge Test, which presents 20 
circular patches containing edges with reducing contrast. Correct identification of the 
orientation of the edge on the patches provides a measure of contrast sensitivity in decibel 
units, where 1 dB = 10 log10 contrast. Proprioception was measured using a lower-limb toe 
matching test, where difference (in degrees) in matching the great toes was recorded using a 
vertical clear acrylic sheet inscribed with a protractor placed between the legs. The 
proprioception test was administered as quickly as possible and rest periods were provided 
between trials to minimise fatigue influencing the test. Quadriceps muscle (isometric) 
strength in kilograms was examined in the more affected leg using a spring gauge while 
participants were seated with the hip and the knee joints at 90° of flexion. Hand reaction time 
in milliseconds was assessed using a light as a stimulus and a finger-depression of a switch as 
the response. Postural sway area (maximal anterior-posterior and medio-lateral sway in mm) 
was quantified using a sway-meter that measured the displacement of the body at waist level 
while participants stood for 30 seconds on a foam rubber mat with their eyes open. This area 
measurement was subsequently converted to an estimate of sway path (a more precise 
measure and better discriminator of fall risk in both older people and people with MS2, 18 ) 
using a regression equation from large population studies.  
The five PPA components were weighted to compute a composite PPA fall risk score 
expressed in standard (z-score) units. In studies of older people, PPA fall risk index scores 
discriminate between multiple and non-multiple fallers with accuracies up to 75%, with 
scores of less than 0 indicating a low risk of falling, 0 to 1 indicating a mild risk, 1 to 2 
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indicating a moderate risk, and scores of 2 indicating a high risk of falling. 
Falls definition and follow up 
In this study two fall definitions were used. For the sample from Australia a fall was defined 
as “unintentionally coming to the ground or other lower level and other than a consequence 
of sustaining a violent blow, loss of consciousness, sudden onset of paralysis as in stroke or 
epileptic or seizure”30. For samples from the UK and US a fall was defined as “a slip or trip 
in which participants came to rest on the ground or floor or lower level”31. Following the 
assessment, participants were asked to prospectively record any falls in the next three months 
using a diary system32. Participants received monthly falls diary sheets, written instructions 
and reply-paid return envelopes. A reminder telephone call or email was sent to participants 
whose diary returns fell behind schedule32.  Previous studies of older people have found that 
recurrent falls are more likely to indicate physiological impairments and chronic conditions 
than single falls, and are therefore more clinically important. In line with previous studies, 
frequent fallers were defined as those who had ≥2 falls in the follow-up period3. 
Statistical analysis 
Descriptive data for the PPA component tests and composite risk scores are presented. These 
include percentiles for those aged 20-39, 40-49, 50-59 and ≥60 years. The proprioception, 
quadriceps strength, reaction time and sway variables were positively skewed, and were log 
transformed to allow further parametric analyses. Pearson correlations were used for 
assessing PPA performance scores, age, and years since MS diagnosis. Group t-tests were 
used to compare the differences in these measures between men and women, between 
prospective fallers and non-fallers, and between frequent fallers (two or more falls in three 
months) and non-frequent fallers (zero or one falls in three months). Finally, PPA 
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performance scores were contrasted between the MS sample and age-matched healthy 
controls without MS using General Linear Models, adjusting for age and gender. Data were 
analyzed with SPSS (version 22) for Windows (SPSS, Chicago, IL, USA). 
RESULTS 
Demographic characteristics of the MS sample 
Demographic characteristics of the sample are presented in Table 1. The MS sample (n =416) 
comprised 305 women (73.3%) and 111 men (26.7%) with mean age 51.5 years (SD = 12.0, 
range = 21-84) and mean years since MS diagnosis 13.7 (SD=9.9). The men and women were 
of similar age 50.8 (SD = 13.0) and 51.8 (SD = 11.6); t1,414=0.76, p=0.45). The mean EDSS 
of the sample was ~ 4 (range = 0 – 6.5). Approximately 62.0% of the sample was diagnosed 
with relapse-remitting MS, 23.8% with secondary progressive MS, 13.5% with primary 
progressive MS and 0.9% unknown. 
Comparison with age-matched controls without MS 
The age-matched control participants without MS sample (n =352) comprised 274 women 
(77.8%) and 78 men (22.2%) with mean age 52.8 years (SD = 12.2, range = 21-84). There 
were non-significant trends for the MS sample to be younger (51.5 (SD-12.0) years vs. 52.8 
(SD=12.2) years, t1,766=1.44,p=0.150 and and comprise fewer women (73.3% vs. 77.8%, 
χ2=2.10,df=1,p=0.15) than the control group. The participants with MS performed 
significantly worse than the control participants without MS in each of the PPA tests and had 
higher PPA composite scores, after adjusting for age and gender in general linear model 
analyses (Table 2). Figure 1 shows mean PPA composite scores for the age-bands presented 
in the MS PPA reference database in relation to composite score norms for healthy control 
participants without MS25-28. 
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PPA reference values for people with MS 
Reference data for both men and women for the five PPA tests and composite fall risk scores 
are presented in Table 3. Men performed similarly to women in all tests, with the exception 
of knee extension strength: 36.7±14.5 and 23.6±91 kg force respectively (t1,414=10.2, 
p<0.001). Performances in all PPA tests were significantly associated with years since 
diagnosis of MS and performance in all PPA tests, with the exception of proprioception, were 
significantly associated with age (Table 4). 
PPA test scores in relation to MS subtypes and disease severity 
Mean ages (SD) for the three MS subtype groups were as follows: Relapsing Remitting - 47.0 
(11.4) years, Secondary Progressive -59.2 (8.8) years and Primary Progressive 58.5 (8.9) 
years (p<0.001). The proprotions of particiants in the three groups who were women were 
74.3%, 72.7% and 67.9% respectively (p=0.61). Table 5 shows the PPA test measures for 
participants with Relapsing Remitting, Secondary Progressive and Primary Progressive MS. 
Significant between-group differences were evident for the visual contrast sensitivity, knee 
extension strength and postural sway tests and PPA composite scores when adjusting for age. 
Figure 2 shows the relationship between PPA composite scores and EDSS categories (Figure 
2). The Pearson correlation coefficient for this association was 0.478 (p<0.001), and this was 
only slightly attenuated when adjusting for age in a partial correlation analysis; r=0.405, 
(p<0.001). PPA and EDSS scores did not differ significantly by gender (p=0.103 and 
p=0.792 respectively). 
Prospective falls 
All MS participants completed the three month follow-up fall calendars. Two hundred and 
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twenty six (226) participants (54.4%) reported having at least one fall in the three month 
follow-up period; 71 (17.1%) fell once, 46 (11.1%) fell twice, 25 (6.0%) fell three times, 22 
(5.3%) fell four times and 62 (14.9%) fell ≥ 5 times. There were 1,350 reported falls in total. 
Table 6 shows the PPA test measures for those who reported 0, 1, 2 and 3+ falls during 
follow-up. Frequent (2+) fallers performed significantly worse than the non-frequent fallers 
in the visual contrast sensitivity, hand reaction time and postural sway tests and had higher 
PPA composite scores. The proportion of participants who suffered multiple falls increased 
with increasing composite PPA scores, i.e. 25.0% in those with scores ≤ 0, 27.4% in those 
with scores > 0 and ≤ 2, 37.5% in those with scores > 2 and ≤ 3 and 56.4% in those with 
scores > 3; ϰ2=28.4, df=3, p<0.001. The area under the receiver-operator characteristic score 
for the composite PPA – frequent faller association was 0.64. 
DISCUSSION 
Our study compared fall risk scores of people with MS to those of a healthy control 
population and examined whether PPA component and composite test performance scores 
discriminated between frequent and non-frequent fallers in this population. We found that the 
MS sample performed significantly worse than the age-matched control participants without 
MS in all PPA tests. Overall, 62% of the MS sample had PPA scores of one or higher 
(moderate fall risk) and 47% had PPA scores of two or higher (high fall risk). This indicates 
that most people with MS are at an increased fall-risk when compared to normative data, and 
as shown in figure 1, fall risk is significantly elevated across the adult lifespan. 
Fall risk was also evident by the high fall rate reported with over 50% of the cohort reporting 
one or more falls and over 37% reporting two or more falls in the three month follow-up. 
Frequent fallers performed significantly worse than the non-frequent fallers in three of the 
five component tests: visual contrast sensitivity, hand reaction time and postural sway, and 
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had higher PPA composite scores. In contrast, there were only trends for the MS sample to 
have reduced lower limb proprioception and knee extension strength. This suggests these 
measures may be less important for fall risk in people with MS compared with older people – 
the population group in which the PPA was developed. For knee extension strength, in 
particular, it appears that performance may be adequate in both frequent and non-frequent 
fallers in people with MS. 
PPA composite score were significantly associated with EDSS scores when adjusting for age, 
and differing fall risk profiles for people with different MS sub-types. The Relapsing 
Remitting group performed best in all PPA tests, and significant between-group differences 
were evident for the visual contrast sensitivity, knee extension strength and postural sway 
tests and PPA composite scores. Noticeably, the Secondary Progressive group had 
significantly poorer knee extension strength than both the Relapsing Remitting and Primary 
Progressive groups and may be a distinguishing risk factor for this group. 
Strengths of this analysis include the rigorous prospective falls surveillance and the 
recruitment of a large sample drawn from three countries with EDSS scores ranging from one 
to 6.5, covering ambulatory people with few symptoms to those with major balance and gait 
impairments. We also acknowledge that while the physiological tests were able to distinguish 
frequent fallers from non-frequent fallers, the area under the receiver-operator characteristic 
score for the composite PPA – frequent faller association was only moderate, and there are 
undoubtedly other general and disease-specific measures such as strength of other muscle 
groups, fine motor control, spasticity, fatigue and dynamic balance steps (such as voluntary 
and reactive stepping) that may have provided additional insight into the fall risk profile in 
people with MS. Further research could provide additional reference data to add to the 
current fall risk profile. Second, due to the differing methods of recruitment within both the 
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MS and healthy control groups, it is not possible for us to present data on response rates. 
Third, while no participants were unable to complete the lower limb proprioception test due 
to not being fully able to extend either leg due to weakness or fatigue, it is acknowledgment 
that as this test involved movements against gravity, test results may have bee affected by 
reduced muscle strength in some participants. Finally, the data presented for sway path are 
indirect as they were estimated from a regression equation from measured maximal anterior-
posterior and lateral sway measurements from the swaymeter. This more robust measure was 
included in the reference database as it can now be measured simply with a mobile 
application (www.neura.edu.au/apps/ppaswaypath) as used in a recent randomized controlled 
trial26  
Clinical implications and conclusions  
This study illustrates the value of a physiological profiling approach to identifying sensory 
and motor impairments and documenting overall reduced physiological performance in 
people with MS25. The compiled reference database for the PPA component and composite 
scores should assist future studies using the PPA in evaluating balance performance and 
evaluating effectiveness of interventions in people with MS. Further, as the PPA comprises 
simple “low tech” tests it has scope for widespread use in clinical settings. 
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Figure 1:  Mean PPA composite scores for the age-bands presented in the MS PPA 
reference database in relation to composite score norms for healthy control participants 
without MS. 
The light blue curved band shows the PPA composite score range across the life span for 
healthy people without MS – top border indicating 75th percentile and bottom border 10th 
percentile. Superimposed on this established relationship are scores for people with MS in 
age-groups 20-39,40-49, 50-59 and 60+ years. The middle of the bubble points indicate the 
age-group mean scores, and the bubble size indicates the age-group standard deviations. 
 
 
 
  
The image part with relationship ID rId9 was not found in the file.
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Table 1: Demographic characteristics of each sample from the three countries 
 Australia 
(n=210) 
UK 
(n=148) 
United States 
(n=58) 
Total sample 
(n=416) 
Age in years: Mean 
(range)  
50.3 (21–73) 58 (33-84) 39.5 (22-50) 51.5(21-84) 
Gender: (F:M) 
(Ratio %) 
150:60 
(71:29) 
114:34    
(77:23) 
41:17 
(71:29) 
305:111 (73:27) 
Years with MS 
(SD) 
13.6 
(8.9) 
16.7 
(10.9) 
6.5 
(5.8) 
13.7 
(9.9) 
EDSS:  
Mean (range)  
3.66 
1.0 - 6.5 
5.0 
3.5 - 6.5 
2.6 
0 - 6.0 
4.03 
0 - 6.5 
Subtype 
  RRMS 
  SPMS 
  PPMS 
  Unknown 
 
160 (76.2%) 
30 (14.3%) 
19 (9.0%) 
1 (0.5%) 
 
42 (28.4%) 
66 (44.6%) 
37 (25%) 
3 (2%) 
 
55 (94.8%) 
3 (5.2%) 
0 
0 
 
257 (61.7%) 
99 (23.8%) 
56 (13.5%) 
4 (0.9%) 
     
EDSS: Expanded Disability Status Scale, RRMS: Relapsing Remitting Multiple Sclerosis; 
SPMS: Secondary Progressive Multiple Sclerosis; PPMS: Primary Progressive Multiple 
Sclerosis 
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Table 2: PPA test and composite scores: MS – control group comparisons 
 
Test measure People with MS Mean 
(SD), N=416 
Non-MS controls 
Mean (SD), N=352 
Visual contrast sensitivity (dB) 21.2 (2.5) 22.0 (2.2)** 
Proprioception (º error) 3.6 (2.6) 2.0 (1.4)*** 
Knee extension strength (kg force) 27.1 (12.3) 30.5 (12.4)*** 
Hand Reaction Time (ms)# 300 (99) 244 (57)*** 
Sway path (mm)# 586 (896) 112 (54)*** 
PPA composite score# 2.15 (1.87) 0.00 (1.11)*** 
* - p < 0.05, *** p<0.001, adjusted for age and sex.  
# Control group N=212, due to measure not included in all control group studies 
Note: low visual contrast sensitivity and knee extension strength scores and high 
proprioception, reaction time, sway and high PPA composite scores indicate impaired 
performance   
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Table 3a: Reference values (percentiles) for PPA component and composite fall risk scores 
for the MS sample – men 
Test Age-
group 
10% 25% 50% 75% 90% 
Visual contrast sensitivity 
(dB) 
      
 20-39 19.8 21.0 22.0 24.0 24.0 
 40-49 18.0 21.0 22.0 24.0 24.0 
 50-59 18.0 21.0 22.0 24.0 24.0 
 60+ 16.6 20.0 21.0 22.0 24.0 
Proprioception (º error)       
 20-39 1.4 2.0 2.8 3.8 4.9 
 40-49 1.4 2.0 2.8 3.8 4.9 
 50-59 1.4 2.1 3.3 5.7 9.7 
 60+ 1.4 2.1 3.3 5.7 9.7 
Knee extension strength 
(kg force) 
      
 20-39 25.4 35.0 44.0 62.0 69.2 
 40-49 22.0 30.3 39.0 48.0 54.0 
 50-59 14.9 28.5 36.0 45.5 52.0 
 60+ 14.9 22.0 28.0 34.0 40.0 
Reaction time (ms)       
 20-39 192 210 229 262 314 
 40-49 208 217 261 300 495 
 50-59 214 227 265 317 469 
 60+ 214 227 265 345 469 
Sway (mm)       
 20-39 72 97 118 369 729 
 40-49 76 119 196 369 729 
 50-59 117 145 268 490 995 
 60+ 123 145 268 490 995 
PPA score       
 20-39 -0.54 -0.47 0.83 2.09 3.32 
 40-49 -0.47 0.25 1.53 2.73 3.93 
 50-59 0.39 0.91 1.93 3.32 5.23 
 60+ 0.40 0.91 1.93 3.32 5.43 
Note: low visual contrast sensitivity and knee extension strength scores and high 
proprioception, reaction time, sway and PPA composite scores indicate impaired 
performance.   
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Table 3b: Reference values (percentiles) for PPA component and composite fall risk scores 
for the MS sample – women 
Test Age-
group 
10% 25% 50% 75% 90% 
Visual contrast 
sensitivity (db) 
      
 20-39 20 21 22 24 24 
 40-49 19 21 22 24 24 
 50-59 19 20 21 22 24 
 60+ 17 19 21 22 23 
Proprioception (º error)       
 20-39 1.0 1.6 2.4 3.3 5.0 
 40-49 1.0 1.6 2.8 4.4 7.4 
 50-59 1.0 1.6 2.8 5.0 7.7 
 60+ 1.0 1.8 3.6 5.4 7.7 
Knee strength       
 20-39 17.0 20.0 25.0 32.0 40.0 
 40-49 13.0 20.0 25.0 32.0 40.0 
 50-59 13.0 17.0 23.0 28.0 34.0 
 60+ 9.6 14.5 20.0 26.0 31.2 
Reaction time (ms)       
 20-39 211 224 246 294 342 
 40-49 214 230 266 312 394 
 50-59 215 245 298 374 460 
 60+ 220 252 314 852 890 
Sway (mm)       
 20-39 80 110 153 351 703 
 40-49 80 122 203 412 995 
 50-59 98 149 264 700 1020 
 60+ 143 202 314 853 1160 
PPA score       
 20-39 -0.28 0.08 1.06 2.03 4.12 
 40-49 -0.10 0.51 1.29 2.92 4.61 
 50-59 0.12 0.99 2.29 3.74 4.95 
 60+ 0.86 1.66 2.41 4.08 5.60 
Note: low visual contrast sensitivity and knee extension strength scores and high 
proprioception, reaction time, sway and PPA composite scores indicate impaired 
performance   
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Table 4: Correlations between physiological and functional tests and duration of MS disease 
and age  
 
 MS duration Age  
Visual contrast sensitivity (dB) -.240*** -.280*** 
Proprioception (º error) .120** .081 
Knee extension strength (kg force) -.228*** -.314*** 
Hand Reaction Time (ms) .171*** .227*** 
Sway path (mm) .244*** .240*** 
PPA score .289*** .312*** 
   
Note: low visual contrast sensitivity and knee extension strength scores and high 
proprioception, reaction time, sway and PPA composite scores indicate impaired 
performance ** p<0.01, *** p<0.001 
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Table 5: PPA test and composite scores: MS sub-group comparisons 
Test measure Relapsing 
Remitting 
Mean (SD) 
Secondary 
Progressive 
Mean (SD) 
Primary 
Progressive 
Mean (SD) 
P* 
Visual contrast 
sensitivity (dB) 
21.8 (2.0)^ 20.2(2.6) 20.6 (3.7) .002 
Proprioception (º error) 3.4 (2.39) 4.0 (2.9) 3.9 (3.2) .590 
Knee extension strength 
(kg force) 
29.0 (13.0)^ 21.8 (8.5)~ 27.7 (12.1) .007 
Hand Reaction Time 
(ms) 
289 (93) 321 (113) 310 (80) .485 
Sway path (mm) 477 (815)^# 814 (1051) 702 (907) .004 
PPA composite score 1.73 (1.77)^# 2.94(1.80) 2.69 (1.94) .002 
* p value for F statistic adjusted for age 
^ Relapsing Remitting vs. Secondary Progressive (p<0.05) 
~ Secondary Progressive vs. Primary Progressive (p<0.05) 
# Relapsing Remitting vs. Primary Progressive (p<0.05) 
Note: low visual contrast sensitivity and knee extension strength scores and high 
proprioception, reaction time, sway and PPA composite scores indicate impaired 
performance 
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Table 6: PPA test and composite scores: faller group comparisons# 
Test measure 0 falls 
N=190 
Mean (SD) 
1 fall 
N=71 
Mean (SD) 
2 falls 
N=46 
Mean (SD) 
3+falls 
N=109 
Mean (SD) 
Visual contrast sensitivity 
(dB) 
21.7 (1.9) 21.4 (2.0) 20.5 (2.9) 20.6 (3.2)*** 
Proprioception (º error) 3.6 (2.6) 3.1 (2.3) 3.3 (2.4) 3.9 (2.9) 
Knee extension strength 
(kg force) 
27.3 (12.0) 28.1 (13.4) 26.4 (12.1) 26.4 (12.2) 
Hand Reaction Time (ms) 292 (85) 291 (77) 301 (112) 318 (118)* 
Sway path (mm) 514 (871) 307 (428) 734 (910) 832 (1078)*** 
PPA composite score 1.87 (1.80) 1.66 (1.39) 2.54 (2.06) 2.80 (2.00)*** 
# Number of falls participants suffered in the 3 month follow-up 
Group t-tests comparing test scores for non-frequent (0,1) and frequent (2+) fallers; * p<0.05, 
*** p<0.001 
Note: low visual contrast sensitivity and knee extension strength scores and high 
proprioception, reaction time, sway and PPA composite scores indicate impaired 
performance 
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